HEMOTAG® Assessment for Short-term Outcomes of Heart Failure [HATS-OFF]
Aventusoft, LLC.
Summary
Evaluation of the HEMOTAG® system in a less controlled environment and concurrently develop the system for use by patients with heart failure.
Description
The overall objective of research is to test, adapt, refine and validate the HEMOTAG® system to be used outside the usual medical care environments to reduce hospital readmissions.
Eligibility
- Age range
- 22+ years
- Sex
- All
- Healthy volunteers
- No
Inclusion Criteria: * Age greater than or equal to 22 years old. * An index hospital admission for ADHF presenting with symptoms, clinical signs, and chest x-ray (CXR) findings of pulmonary congestion, receiving IV diuretics or vasoactive drugs and having a BNP \> 350 or NT-pro BNP \> 1800 pg/ml. * Able to give informed consent. * Participant's residence has adequate cellular data coverage. * Participants with previous diagnosis of left ventricular ejection fraction (LVEF) \<40% prior to the index hospitalization must have been treated for at least 90 days prior to enrollment with diuretics a…
Interventions
- Diagnostic TestStandard of Care with Hemotag
Comparison of outcomes
Locations (2)
- Cleveland Clinic FloridaWeston, Florida
- Baylor Scott & White Research InstituteTemple, Texas